Cargando…
Gene expression signatures: biomarkers toward diagnosing multiple sclerosis
Identification of biomarkers contributing to disease diagnosis, classification or prognosis could be of considerable utility. For example, primary methods to diagnose multiple sclerosis include magnetic resonance imaging and detection of immunologic abnormalities in cerebrospinal fluid. We determine...
Autores principales: | Tossberg, John T., Crooke, Philip S., Henderson, Melodie A., Sriram, Subramaniam, Mrelashvili, Davit, Chitnis, Shilpa, Polman, Chris, Vosslamber, Saskia, Verweij, Cor L., Olsen, Nancy J., Aune, Thomas M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291793/ https://www.ncbi.nlm.nih.gov/pubmed/21938015 http://dx.doi.org/10.1038/gene.2011.66 |
Ejemplares similares
-
Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis
por: Tossberg, John T, et al.
Publicado: (2013) -
Defective structural RNA processing in relapsing-remitting multiple sclerosis
por: Spurlock, Charles F, et al.
Publicado: (2015) -
Expression of IL-33 and its epigenetic regulation in multiple sclerosis
por: Zhang, Fanglin, et al.
Publicado: (2014) -
Using gene expression data to identify certain gastro-intestinal diseases
por: Crooke, Philip S, et al.
Publicado: (2012) -
Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients
por: van Baarsen, Lisa G. M., et al.
Publicado: (2008)